Option Care Health, Inc. (NASDAQ:OPCH) Shares Sold by Connor Clark & Lunn Investment Management Ltd.

Connor Clark & Lunn Investment Management Ltd. lowered its holdings in Option Care Health, Inc. (NASDAQ:OPCH) by 41.5% in the 1st quarter, according to its most recent Form 13F filing with the Securities & Exchange Commission. The institutional investor owned 230,365 shares of the company’s stock after selling 163,654 shares during the period. Connor Clark & Lunn Investment Management Ltd. owned approximately 0.14% of Option Care Health worth $8,051,000 as of its most recent SEC filing.

Several other large investors also recently made changes to their positions in the business. Townsquare Capital LLC acquired a new stake in shares of Option Care Health in the first quarter worth $692,000. Headlands Technologies LLC increased its position in shares of Option Care Health by 299.9% in the first quarter. Headlands Technologies LLC now owns 61,834 shares of the company’s stock worth $2,161,000 after acquiring an additional 46,371 shares in the last quarter. Charles Schwab Investment Management Inc. increased its position in shares of Option Care Health by 4.0% in the first quarter. Charles Schwab Investment Management Inc. now owns 2,609,705 shares of the company’s stock worth $91,209,000 after acquiring an additional 99,574 shares in the last quarter. Wealthspire Advisors LLC acquired a new stake in shares of Option Care Health in the first quarter worth $206,000. Finally, Geneva Capital Management LLC increased its position in shares of Option Care Health by 5.1% in the first quarter. Geneva Capital Management LLC now owns 781,625 shares of the company’s stock worth $27,318,000 after acquiring an additional 38,105 shares in the last quarter. Institutional investors and hedge funds own 98.05% of the company’s stock.

Option Care Health Trading Down 1.2%

NASDAQ OPCH opened at $27.85 on Tuesday. Option Care Health, Inc. has a 12 month low of $21.39 and a 12 month high of $35.53. The company has a debt-to-equity ratio of 0.81, a current ratio of 1.52 and a quick ratio of 1.00. The company has a market capitalization of $4.52 billion, a price-to-earnings ratio of 22.28, a price-to-earnings-growth ratio of 1.78 and a beta of 0.79. The company’s fifty day moving average price is $30.56 and its two-hundred day moving average price is $31.93.

Option Care Health (NASDAQ:OPCH) last posted its quarterly earnings data on Wednesday, July 30th. The company reported $0.41 EPS for the quarter, beating analysts’ consensus estimates of $0.40 by $0.01. Option Care Health had a net margin of 3.93% and a return on equity of 17.53%. The firm had revenue of $1.42 billion for the quarter, compared to the consensus estimate of $1.35 billion. During the same period in the prior year, the firm posted $0.30 EPS. The firm’s revenue was up 15.4% compared to the same quarter last year. As a group, research analysts predict that Option Care Health, Inc. will post 1.22 earnings per share for the current fiscal year.

Analyst Upgrades and Downgrades

Several research firms have recently issued reports on OPCH. JMP Securities increased their price objective on shares of Option Care Health from $36.00 to $38.00 and gave the stock a “market outperform” rating in a research report on Thursday, July 31st. UBS Group upgraded shares of Option Care Health from a “neutral” rating to a “buy” rating and upped their target price for the company from $38.00 to $40.00 in a research note on Wednesday, April 30th. Barrington Research restated an “outperform” rating and issued a $38.00 target price on shares of Option Care Health in a research note on Thursday, July 10th. Finally, Citigroup restated an “outperform” rating on shares of Option Care Health in a research note on Thursday, July 31st. One analyst has rated the stock with a hold rating and eight have given a buy rating to the stock. According to data from MarketBeat, the company currently has an average rating of “Moderate Buy” and a consensus target price of $35.75.

About Option Care Health

Option Care Health, Inc offers home and alternate site infusion services in the United States. The company provides anti-infective therapies; home infusion services to treat heart failures; home parenteral nutrition and enteral nutrition support services for numerous acute and chronic conditions, such as stroke, cancer, and gastrointestinal diseases; immunoglobulin infusion therapies for the treatment of immune deficiencies; and treatments for chronic inflammatory disorders, including crohn’s disease, plaque psoriasis, psoriatic arthritis, rheumatoid arthritis, ulcerative colitis, and other chronic inflammatory disorders.